Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease

INTRODUCTION: There are no empiric data to support guidelines for duration of therapy with antidementia drugs. This study examined whether persistent use of antidementia drugs slows clinical progression of Alzheimer disease (AD) assessed by repeated measures on serial tests of cognition and function...

Full description

Saved in:
Bibliographic Details
Main Authors: Rountree, Susan D, Chan, Wenyaw, Pavlik, Valory N, Darby, Eveleen J, Siddiqui, Samina, Doody, Rachelle S
Format: Artigo
Language:Inglês
Published: BioMed Central 2009
Subjects:
Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2874259/
https://ncbi.nlm.nih.gov/pubmed/19845950
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/alzrt7
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items